Loading...
Please wait, while we are loading the content...
Laser Prophylaxis for Age-Related Macular Degeneration
| Content Provider | Scilit |
|---|---|
| Copyright Year | 2007 |
| Description | Age-related macular degeneration (AMD) is theleading cause of visual loss in people older than 65years in the United States (1-6). Approximately200,000 Americans per year lose central vision due toAMD and 50,000 will lose vision in both eyes.Currently, there are an estimated 38 million Americanseniors with a projected 88 million by 2030, which willlead to a proportional increase in the population at riskfrom vision loss due to AMD. Ninety percent of thesevere visual loss from AMD results from choroidalneovascularization (CNV) (2,7,8). Although thermallaser photocoagulation, photodynamic therapy, andvarious drug therapies to treat neovascular AMD areavailable or on the horizon, they have only proven tobe moderately effective and applicable to a subset ofpatients (9-18). As a result, the development ofpreventive strategies for patients at high risk of devel-oping CNV is very desirable. Even a modestly effectivebilateral preventive treatment can have a substantialimpact on the development of late AMD (geographicatrophy and/or CNV) and the rate of legal blindnesscaused by CNV. According to one estimate, an inter-vention that reduced the risk of developing CNV byjust 30% in eyes of patients with bilateral large drusencould eventually halve the rate of bilateral blindnessfrom AMD (19). Book Name: Age-Related Macular Degeneration |
| Related Links | https://www.taylorfrancis.com/chapters/mono/10.3109/9781420019865-23/laser-prophylaxis-age-related-macular-degeneration-jennifer-lim |
| Ending Page | 290 |
| Page Count | 16 |
| Starting Page | 275 |
| DOI | 10.3109/9781420019865-23 |
| Language | English |
| Publisher | Informa UK Limited |
| Publisher Date | 2007-10-18 |
| Access Restriction | Open |
| Subject Keyword | Book Name: Age-Related Macular Degeneration Degeneration |
| Content Type | Text |
| Resource Type | Chapter |